Your Article Summary
See Latest ArticlesFluocinolone Acetonide 0.01% in Peanut Oil: Safety and Efficacy Data in the Treatment of Childhood Atopic Dermatitis in Infants as Young as 3 Months of Age
Pediatric Dermatology, 06/26/09
Dohil MA et al. - Results of the study support the safety and efficacy of fluocinolone acetonide 0.01% in refined peanut oil vehicle, for infants as young as 3 months of age with atopic dermatitis. No evidence of adrenal suppression or adverse local effects was demonstrated after 4 weeks of twice daily treatment.
Related Articles
Topical tacrolimus as treatment of atopic dermatitis
Clinical, Cosmetic and Investigational Dermatology, 11/11/09
Relevance Score: 67%
Topical Pimecrolimus: A Review of its Use in the Management of Pediatric Atopic Dermatitis
Pediatric Drugs, 11/06/09
Relevance Score: 67%
Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis
Pediatric Allergy and Immunology, 10/15/09
Relevance Score: 67%
Association of the toll-like receptor 2 A-16934T promoter polymorphism with severe atopic dermatitis
Allergy, 10/13/09
Relevance Score: 67%
Structured education program improves the coping with atopic dermatitis in children and their parents--a multicenter, randomized controlled trial
Journal of Psychosomatic Research, 10/09/09
Relevance Score: 67%
Today in Derm Allergy/Immunology...keeping you current
Receive free subspecialty "5-minute updates" via email
Temperature modulated histamine-itch in lesional and nonlesional skin in atopic eczema a combined psychophysical and neuroimaging study
Allergy, 12/18/09
Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults
Journal of the European Academy of Dermatology and Venereology, 12/17/09
Differential requirements for IL-4/STAT6 signalling in CD4 T-cell fate determination and Th2-immune effector responses
Immunology & Cell Biology, 12/17/09